Skip to main content

Mechanical Thrombectomy Safe, Effective for High-Risk Pulmonary Embolism

Medically reviewed by Carmen Pope, BPharm. Last updated on Dec 1, 2023.

By Lori Solomon HealthDay Reporter

FRIDAY, Dec. 1, 2023 -- Mechanical thrombectomy (MT) is safe and effective in real-world, high-risk patients with pulmonary embolism (PE), according to a study published online Oct. 31 in the Journal of the Society for Cardiovascular Angiography & Interventions.

James M. Horowitz, M.D., from the NYU Grossman School of Medicine in New York City, and colleagues assessed the safety and effectiveness of MT for high-risk PE. The analysis included 63 real-world, high-risk patients identified through the multicenter FlowTriever All-comer Registry for Patient Safety and Hemodynamics study.

The researchers found that 47.6 percent of patients showed a systolic blood pressure <90 mm Hg, 46.0 percent required vasopressors, and 6.3 percent experienced cardiac arrest. At baseline, 72.6 percent of patients were tachycardic, 54.5 percent showed elevated lactate levels of ≥2.5 mM, and 42.9 percent showed a depressed cardiac index of <2 L/min/m2. Heart rate improved immediately after MT to 93.5 beats per minute. Twenty-five patients (42.4 percent) did not require an overnight stay in the intensive care unit. No mortalities or major adverse events occurred through 48 hours, and at 30-day follow-up, no mortalities occurred.

"Our findings highlight the effectiveness of mechanical thrombectomy as a first-line treatment for high-risk pulmonary embolism," Horowitz said in a statement. "By removing blood clots from the lungs, this procedure can rapidly restore blood flow and prevent fatal complications."

Several authors disclosed ties to the medical technology industry.

Abstract/Full Text

Editorial

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

GLP1 Receptor Agonists Do Not Up Risk for Complications After Emergency Surgery

THURSDAY, April 25, 2024 -- The risk for postoperative respiratory complications is similar among patients undergoing emergency surgery regardless of preoperative glucagon-like...

Wearable Technology During Surgery Provides Neurosurgeons With Postural Info

WEDNESDAY, April 24, 2024 -- Wearable technology is feasible to assess postural ergonomics and provide objective biofeedback to neurosurgeons, according to a pilot study published...

Knee Osteoarthritis Symptoms Common After ACL Reconstruction

TUESDAY, April 23, 2024 -- Nearly one-quarter of patients show persistent early knee osteoarthritis (OA) symptoms six to 12 months after anterior cruciate ligament reconstruction...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.